Calabash Bioscience Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Out of Business

Calabash Bioscience General Information

Description

Developer of pharmaceutical products. The company's products include novel compounds for rapid reversal of neuromuscular block, enabling patients to quickly transit from the operating room to recovery.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 387 Technology Drive
  • Suite 3119
  • College Park, MD 20742
  • United States
+1 (240) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Calabash Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 02-Feb-2019 00000 Completed Out of Business
1. Early Stage VC 23-Apr-2015 00000 00000 Completed Generating Revenue
To view Calabash Bioscience’s complete valuation and funding history, request access »

Calabash Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial